What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Cancer
Allan D. Kirk mainly investigates Immunology, Transplantation, Kidney transplantation, Internal medicine and Kidney.
His research investigates the link between Immunology and topics such as Biopsy that cross with problems in Infiltration.
The concepts of his Transplantation study are interwoven with issues in Immunosuppression, Islet and Sirolimus.
Allan D. Kirk has included themes like Creatinine, Immune system and Urology in his Kidney transplantation study.
His Kidney research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Kidney disease.
His study in Monoclonal antibody is interdisciplinary in nature, drawing from both Allotransplantation, CD154 and Isoantibodies.
His most cited work include:
- CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates (877 citations)
- Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. (765 citations)
- Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. (765 citations)
What are the main themes of his work throughout his whole career to date?
Allan D. Kirk mainly focuses on Immunology, Transplantation, Immunosuppression, Immune system and Kidney transplantation.
His Immunology study incorporates themes from Blockade, Belatacept and Sirolimus.
His research in Transplantation intersects with topics in Kidney, Antigen and Islet.
His Immunosuppression research incorporates themes from Clinical trial, Regimen, Tacrolimus, Immune tolerance and Organ transplantation.
His Kidney transplantation study combines topics in areas such as Biopsy, Pharmacology and Urology.
His work carried out in the field of Monoclonal antibody brings together such families of science as CD154 and CD40.
He most often published in these fields:
- Immunology (65.30%)
- Transplantation (45.91%)
- Immunosuppression (20.69%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (65.30%)
- Transplantation (45.91%)
- Belatacept (14.22%)
In recent papers he was focusing on the following fields of study:
Allan D. Kirk focuses on Immunology, Transplantation, Belatacept, Immune system and Immunosuppression.
His Immunology research includes themes of Cancer research and Kidney transplantation.
His Transplantation research includes elements of Intensive care medicine, Antigen and Islet.
His biological study spans a wide range of topics, including Sirolimus, Urology, Regimen, Calcineurin and Immunotherapy.
His Immune system research focuses on B cell and how it connects with Carboxyfluorescein succinimidyl ester, Lymphocyte and Lymphocyte proliferation.
His Immunosuppression research is multidisciplinary, relying on both Recent Thymic Emigrant, Tacrolimus, Peripheral blood mononuclear cell and Pathology.
Between 2015 and 2021, his most popular works were:
- APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. (94 citations)
- Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing. (81 citations)
- CD57+ CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Cancer
Allan D. Kirk spends much of his time researching Immunology, Immune system, Belatacept, Calcineurin and Transplantation.
The Immunology study combines topics in areas such as Sirolimus and Kidney transplantation.
The study incorporates disciplines such as Kidney, Cell adhesion molecule and Physiology in addition to Immune system.
His Belatacept course of study focuses on Regimen and Urology, Immune tolerance, Myeloid and Busulfan.
His Calcineurin study combines topics from a wide range of disciplines, such as Blockade, Antigen and Immunosuppression.
His research integrates issues of Renal function and Islet in his study of Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
